Skip to content

33% of IBD Patients Will Experience Skin Lesions at Some Point

Hey UC’ers,

Here is a study that caught my eye.  Especially considering the skin lesions (skin rash, eczema) issues I dealt with after starting Humira about 7 years ago.  I was a bit shocked to read that one third of those with IBD will deal with skin issues at some point.  Give us a break right…

This study showed some positive outcome for a UC’er and I thought that some of you would be interested, and maybe able to share this with your GI docs in case they are not up to speed on this.(Just tell them Dr. Rubin was behind much of the research if they don’t give you the time of day…he is often thought of the world’s leading/premier…whatever you want to label it GI doc in terms of IBD…but I’m sure there are many great ones like him..I hope:)

Here is a picture of what this might look in case you have not heard of or seen this:

Psoriasiform plaques on the patient's palms during infliximab treatment.(infliximab is

Psoriasiform plaques on the patient’s palms during infliximab treatment.(infliximab is “Remicade

And below is a picture of me quite a few years ago sitting on the beach…check out the nice colors on them legs…:

Below is the “abstract” or high level summary of the study that was led by members of the world class University of Chicago Medicine, Inflammatory Bowel Disease Center, and if you want to read the whole study you can click on the link directly below:

Psoriatic skin lesions associated with anti-tumor necrosis factor (TNF) agents are well-described in the medical literature. However, the etiology and optimal management of this condition remain unclear. Vedolizumab is a novel, gut-specific, anti-integrin agent used for the treatment of inflammatory bowel disease (IBD). We report a case of infliximab-associated psoriasiform lesions in an ulcerative colitis patient. Transition to vedolizumab resulted in resolution of the cutaneous lesions without recurrence and remission of his ulcerative colitis.

Click Here To Read the FULL ARTICLE

Also, if you are wanting to do some further research into the medication that is mentioned in the study “Vedolizumab” you can read more directly here on the ihaveuc site pages associated with that medication (which is also called Entyvio):

Vedolizumab/Entyvio informational pages:

Information about Entyvio or Vedolizumab (New Medication)

Entyvio or “Vedolizumab” Reviews – the Integrin Antagonist

Thanks again, and have a great weekend,

 

Adam